Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Physiological Models

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Co-Producing a Package of Novel Online Resources to Support the Mental Health Needs of People With Persistent Pain: BeeFree.

Musculoskeletal care·2024

Same author

The SelfSTarT intervention for low back pain patients presenting to first contact physiotherapists: A mixed methods service evaluation.

Musculoskeletal care·2024

Same author

Physician Assisted Death for Psychiatric Suffering: Experiences in the Netherlands.

Frontiers in psychiatry·2022

Same author

A reassessment of TBT action levels for determining the fate of dredged sediments in the United Kingdom.

Marine pollution bulletin·2022

Same author

The transcription factor scleraxis differentially regulates gene expression in tenocytes isolated at different developmental stages.

Mechanisms of development·2020

Same author

The experience of using prompting technology from the perspective of people with Dementia and their primary carers.

Aging & mental health·2020

Same journal

Optimizing Clinical Study Designs for CAR-T Cell Therapy: Development of an Efficient Sampling Strategy Through Optimal Experimental Design.

CPT: pharmacometrics & systems pharmacology·2026

Same journal

Best Practices in Physiologically Based Pharmacokinetic (PBPK) Modeling.

CPT: pharmacometrics & systems pharmacology·2026

Same journal

Integrated Population Pharmacokinetic Analysis of Intravitreal Aflibercept Drug Products.

CPT: pharmacometrics & systems pharmacology·2026

Same journal

Development and Use of a Population Pharmacokinetic Model for Characterizing the Pharmacokinetics of Vonoprazan in Pediatric Patients.

CPT: pharmacometrics & systems pharmacology·2026

Same journal

A Narrative Review of Artificial Intelligence for Drug Repurposing: Lessons From COVID-19 and Oncology (2020-2025).

CPT: pharmacometrics & systems pharmacology·2026

Same journal

Butorphanol Pharmacokinetics Across Species: Meta-Analysis Integrating Allometric Scaling and Minimal Physiologically Based Pharmacokinetic Modeling.

CPT: pharmacometrics & systems pharmacology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 6, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

Modeling and Simulation Approaches for Cardiovascular Function and Their Role in Safety Assessment.

T A Collins¹, L Bergenholm², T Abdulla²

¹Drug Safety and Metabolism, AstraZeneca Alderley Park, Macclesfield, UK.

CPT: Pharmacometrics & Systems Pharmacology

|July 31, 2015

Summary

This summary is machine-generated.

Systems pharmacology modeling and pharmacokinetic-pharmacodynamic (PK/PD) analysis are vital for assessing drug safety. This review covers current modeling and simulation (M&S) approaches for drug-induced cardiovascular effects and suggests future research directions.

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

Related Experiment Videos

Last Updated: Apr 6, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

In Silico Clinical Trials for Cardiovascular Disease

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

Area of Science:

Pharmacology
Drug Safety
Computational Biology

Background:

Cardiovascular (CV) safety is a critical concern in new drug development.
Understanding drug-induced CV effects is essential for risk assessment.

Purpose of the Study:

To review current modeling and simulation (M&S) approaches for drug-induced CV effects.
To emphasize the impact of these approaches on drug safety assessment.
To identify limitations and propose future research directions.

Main Methods:

Review of existing systems pharmacology models.
Analysis of pharmacokinetic-pharmacodynamic (PK/PD) modeling techniques.
Evaluation of M&S strategies for translating preclinical data to clinical CV outcomes.

Main Results:

Current M&S approaches provide valuable insights into drug-induced CV effects.
PK/PD modeling is a key tool for predicting and understanding these effects.
Limitations exist in current methodologies for comprehensive safety assessment.

Conclusions:

M&S of drug-induced CV effects is crucial for drug safety.
Further research is needed to refine methodologies and address current limitations.
Enhanced predictive models will improve the safety evaluation of novel therapeutics.